Prosthetic Heart Valve Market is expected to grow at a 11.4% CAGR between 2022 and 2032 – Exclusive Report by FMI

The global prosthetic heart valve market is prosthetic heart valve market was valued at US$ 10.9 billion in 2021 and is expected to reach US$ 12.3 billion by the end of 2022. With the increasing prevalence of valvular disorders such as aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation, the overall demand for prosthetic valves is expected to grow at a 11.4% CAGR between 2022 and 2032, reaching US$ 36.3 billion by 2032.

However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Request a Sample of this Report @

Segmental Forecast:

  • The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
  • The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional Market Overview:

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.

Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Request for Customization @

Leading market players are focusing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include: product approvals and commercialization, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

Prosthetic Heart Valve Market Key Segmentation:

By Product Type

  • Mechanical Heart Valves
  • Mechanical Aortic Valve
  • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
  • Tissue Aortic Valve
  • Tissue Mitral Valve
  • Transcatheter Heart Valves
  • Transcatheter Aortic Valve
  • Transcatheter Mitral Valve

By End User

  • Hospitals
  • Ambulatory Surgery Centres

By Region

  • North America
  • Latin America Excluding Brazil
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Middle East & Africa (MEA)

Speak to our Research Expert @

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these